Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |